• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Lexicon Pharmaceuticals, Inc. (LXRX)

    -NasdaqGS
    1.10 Up 0.03(2.80%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 22,854   2,222   1,089  
    Cost of Revenue -   -   -  
    Gross Profit 22,854   2,222   1,089  
    Operating Expenses
    Research Development89,279  89,682  82,574  
    Selling General and Administrative20,839  14,911  26,930  
    Non Recurring13,102   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (100,366) (102,371) (108,415)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,255  216  318  
    Earnings Before Interest And Taxes(98,111)(102,155)(108,097)
    Interest Expense2,253  1,971  2,114  
    Income Before Tax(100,364)(104,126)(110,211)
    Income Tax Expense(70) -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(100,294)(104,126)(110,211)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (100,294) (104,126) (110,211)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (100,294) (104,126) (110,211)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.